Investigation of Anti-diabetic and Hypocholesterolemic Potential of Psyllium Husk Fiber (Plantago psyllium) in Diabetic and Hypercholesterolemic Albino Rats

The present study was conducted to observe the effect of Plantago psyllium on blood glucose and cholesterol levels in normal and alloxan induced diabetic rats. To investigate the effect of Plantago psyllium 40 rats were included in this study divided into four groups of ten rats in each group. One group A was normal, second group B was diabetic, third group C was non diabetic and hypercholesterolemic and fourth group D was diabetic and hypercholesterolemic. Two groups B and D were made diabetic by intraperitonial injection of alloxan dissolved in 1mL distilled water at a dose of 125mg/Kg of body weight. Two groups C and D were made hypercholesterolemic by oral administration of powder cholesterol (1g/Kg of body weight). The blood samples from all the rats were collected from coccygial vein on 1st day, then on 21st and 42nd day respectively. All the samples were analyzed for blood glucose and cholesterol level by using enzymatic kits. The blood glucose and cholesterol levels of treated groups of rats showed significant reduction after 7 weeks of treatment with Plantago psyllium. By statistical analysis of results it was found that Plantago psyllium has anti-diabetic and hypocholesterolemic activity in diabetic and hypercholesterolemic albino rats.




References:
[1] D. W. Guthrie, and R. A. Guthrie, "Diabetes. The Diabetes Sourcebook.
Los Angeles: Lowell House Publications., vol. 16, pp. 8-25, 1999.
[2] S. P. Wolff, "Diabetes mellitus and free radiacals," Br Med Bull., vol.
49, pp. 642-652, 1993.
[3] A. Robert, W. A. Wenatchee, F. L. Tallahassee, and S. R. Lynn,
"Association of Diabetes with genetic & environmental factors,"
University of Maryland Medical Center. Diabetes., vol. 18 pp. 446-452,
1999.
[4] Anonymous, "Low Density lipoprotein as Bad Cholesterol,"
URL=http://en. wikipedia .org /wiki/low_density_lipoprotein., 2008.
[5] M. C. Garg, S. Ojha, and D. D. Bansal, "Anti-oxidant status of
Streptozotocin in diabetic rats," Indian J Exp. Bio., vol. 34, pp. 264-
266, 1996.
[6] M. C. Sabu, and K. Ramadasan, "Anti-diabetic activity of medicinal
plants and its relationship with their anti-oxidant property," J.
Ethnopharmaco., vo. 81, pp. 155-160, 2002.
[7] L. Johadar, "Plants with hypoglycemic effects." Cesk farm., vol. 42, pp.
251-259, 1993.
[8] D. Sathishsekar, and S. Subramanian, "Beneficial effects of Momordica
Charantia seeds in the treatment of STZ-induced diabetes in
experimental rats," Biol. Pharm. Bull., vol. 28, pp. 978-983, 2005.
[9] K. G. Mehta, R. Modi, and R. Gupta, "Psyllium," Indian J Argon., vol.
21, pp. 509-510, 1976.
[10] R. N. Chopra, S. L. Nayar, and I. C. Chopra, "Glossary of Indian
Medicinal Plants (including the supplement). New Delhi: Council of
Scientific and Industrial Research. Vol. 43, pp. 56-67, 1986.
[11] Z. D. Abraham, and T. Mehta, "Three-week psyllium husk
supplementation: Effect on plasma cholesterol concentrations, fecal
steroid excretion, and carbohydrate absorption in men," Am J Clin
Nutr., vol. 47, pp. 67-74, 1988.
[12] N. Washington, M. Harris, A. Mussellwhite, and R. C. Spiller,
"Moderation of lactulose-induced diarrhea by psyllium: effects on
motility and fermentation," Am. J Clin Nutr., vol. 7, pp. 317-321, 1998.
[13] M. L. Fernandez, "Soluble fiber and nondigestible carbohydrate effects
on plasma lipids and cardiovascular risk," Curr Opin Lipidol., vol. 12,
pp. 35-40, 2001.
[14] H. Terpstra, J. A. Lapre, H. T. Vares, and A. C. Beynen,
"Hypocholestrolemic effect of dietry psyllium in female rats," Ann Nutr
Metab., vol. 44, pp. 223-228, 2000.
[15] R. Burton, and V. Manninen, "Influence of a psyllium-based fibre
preparation on feacal and serum parameters," Acta Med Scand., vol.
668, pp. 91-94, 1982.
[16] L. Romero, K. L. West, T. Zern, and M. L. Fernandez, "The seeds from
P. ovata lower plasma lipid by altering hepatic and bile acid metabolism
in guinea pigs," J Nutr., vol. 132, pp. 1194-1198, 2002.
[17] M. A. Pereira, O. E. Reilly, and K. Augusstsson, "Dietary fiber and risk
of coronary heart disease. A pooled analysis of cohort studies," Arch
Intern Med., vol. 164, pp. 370-376, 2004.
[18] L. Brown, B. Rosner, W. W. Willett, and F. M. Sacks, "Cholesterollowering
effects of dietary fiber: a meta-analysis," Am. J. Clin Nutr.,
vol. 69, pp. 30-42, 1999.
[19] R. M. Krauss, R. H. Eckel, and B. Howard, "AHA dietary guidelines
revision 2000 a statement for healthcare professionals from the Nutrition
Committee of the American Heart Association,Circulation" vol. 102, pp.
2284-2299, 2000.
[20] G. Backer, E. Ambrosioni, and R. B. Johnsen, "European guidelines on
cardiovascular disease prevention in clinical practice. Third Joint Task
Force on European and other societies on Cardiovascular Disease
Prevention in Clinical Practice," Eur Heart J., vol. 24, pp. 1601-1610,
2003.
[21] P. G. Reeves, F. H. Nielsen, and G. C. Fahey, "AIN-93 purified diets for
laboratory rodents: final report of the American institute of nutrition Ad
Hoc writing committee on reformulation of the AIN-76 rodent diet," J.
Nutr., vol. 123, pp. 1939-1351, 1993.
[22] A. Junod, A. E. Lambert, W. Staufacher, and A. E. Renold,
"Diabetogenic action of streptozotocin: relationship of dose to metabolic
response," J Clin Invest., vol. 48, pp. 2129-2139, 1996.
[23] N. Vinuthan, S. Kanthasamy, S. William, S. Subramanian, and S.
Govindasamy, "Insulinic action of vanadate on experimental diabetes,"
Pharmacol. Res., vol. 22, pp. 207-217, 2007.
[24] E. M. Mackey, and L. L. Macky "Estimation of serum glucose and
cholesterol," J. Clin. Investigations., vol. 6, pp. 297, 1972.
[25] R. G. D. Steel, J. H. Torrie, and D. A. Dicky, "Principles and Procedure
of Statistics. A biometrical approach," WCB McGraw Hill Book Co.
Inc. New York. vol. 3, pp. 25-31, 1997.
[26] S. L. Abbate, and J. D. Brunzell, "Pathophysiology of hyperlipidemia in
diabetes," J. cardiovascular pharmacol., vol. 16, pp. 1-7, 1990.
[27] M. Safdar, K. Alam, and Habibullah, "Effect of jaman fruit extract on
serum, glucose and lipid profile in type -2 Diabetic Individuals," Pak. J.
Nutr., vol. 5, pp. 573-576, 2006.
[28] F. J. Alarcon, R. R. Ramos, and S. P. Gutierrez, "Studyof the antihyperglycemic
effect of plants used as anti-diabetics," J.
Ethnopharmacol., vol. 61, pp. 101-110, 1998.
[29] S. A. Moharib, and S.A. Batran, "Hypoglycemic effect of dietary fiber in
diabetic rats," Research J. Agri. Biol. Sci., vol. 4, pp. 455-461, 2008.
[30] M. M. Rodriguez, R. F. Guerrero, and B. G. Lazcano, "Lipid- and
glucose-lowering efficacy of Plantago Psyllium in type II diabetes," J.
Diabetes Complications., vol. 12, pp. 273-278, 1998.
[31] D. Kritchevsky, S. A. Tepper, and D. M. Klurfeld, "Influence of
psyllium preparations on plasma and liver lipids of cholesterol-fed rats,"
Artery" vol. 21, pp. 303-11, 1995.
[32] S. A. Ziai, B. Larijani, S. Akhoondzadeh, H. Fakhrzadeh, A. Dastpak, F.
Bandarian, A. Rezai, H. N. Badi, and T. Emami, "Psyllium decreased
serum glucose and glycosylated hemoglobin significantly in diabetic
outpatients," J. Ethnopharmacol., vol. 102, pp. 202-207, 2005.
[33] B. H. Arjmandi, E. Sohn, S. Juma, S. R. Murthy, and B. P. Daggy,
"Native and partially hydrolyzed psyllium have comparable effects on
cholesterol metabolism in rats," Nutr., vol. 127, pp. 463-469, 1997.